 
The Patent Office Journal 31/08/2012 
13814
(12) PATENT APPLICATION PUBLICATION (21) Application No.910/MUMNP/2012 A 
(19) INDIA  
(22) Date of filing of Application :12/04/2012 (43) Publication Date : 31/08/2012 
  
(54) Title of the invention : RECOMBINANT HUMAN CC10 PROTEIN FOR TREATMENT OF INFLUENZA  
  
(51) International classification  :A61K 45/00  
(31) Priority Document No  :61/252,028  
(32) Priority Date  :15/10/2009 
(33) Name of priority country  :U.S.A. 
(86) International Application No 
        Filing Date 
:PCT/US2010/052527
:21/04/2011 
(87) International Publication No  :WO/2011/047065  
(61) Patent of Addition to Application 
Number  
        Filing Date 
:NA 
:NA 
(62) Divisional to Application Number 
        Filing Date 
:NA 
:NA  
  
(71)Name of Applicant :  
   1)CLARASSANCE, INC. 
      Address of Applicant :9700, GREAT SENEEA HIGHWAY, 
ROCKVILLE, MD 20850  U.S.A. 
(72)Name of Inventor : 
   1)PILON, APRILE L 
   2)BORGEAT, PIERRE PH., D 
   3)FLAMAND, LOUIS PH., D  
(57) Abstract : 
Methods of using recombinant human CClO (rhCC10), also known as recombinant human uteroglobin, to reduce virus titers in the 
tissues of patients, particularly influenza titers in lung tissues are provided. RhCC10 may be used as a therapeutic in the treatment, 
cure, or prevention of viral infection, particularly influenza infection. More particularly, methods, including broadly the critical dosage 
ranges of rhCC10, intravenous and intranasal route of administration, which may be administered to treat, cure or prevent influenza 
infection are provided. Further provided are compositions useful in the foregoing methods and in administering rhCC10 to humans. 
  
  
No. of Pages : 22 No. of Claims : 12 
